Proteostasis Therapeutics Inc (NASDAQ:PTI)

Delayed Data
As of Mar 21
 +0.31 / +6.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Proteostasis Therapeutics Inc have a median target of 15.00, with a high estimate of 25.00 and a low estimate of 8.00. The median estimate represents a +174.22% increase from the last price of 5.47.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Proteostasis Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.67%
Growthannually 11.25%


Growthquarterly -36.44%
Growthannually 6.46%
Key to the earnings and sales forecast charts.